GI262570, a tyrosine-based PPARγ agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatment

✍ Scribed by Lata Kler; Robert C. Edwards; Simon J. McNeil; Patrick Round

• Book ID: 117369692
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 207 KB
• Volume: 50
• Category: Article
• ISSN: 0168-8227
• DOI: 10.1016/s0168-8227(00)81593-4